6533b871fe1ef96bd12d0a4b

RESEARCH PRODUCT

Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study

M ClericoS De MercantiF PiazzaD GnedM BresciaR LanzilloL AmaoM QuarantelliA GrezziA BianchiD BarbonciniM GibbinJ VargasMt FerròF VitettaL MascoloD PaolicelliM TrojanoL. DurelliGiuseppe SalemiSabrina Realmuto

subject

natalizumab multiple sclerosishttp://hdl.handle.net/10447/72821